Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Directorate Change

5 Dec 2019 07:00

RNS Number : 7316V
CATCo Reinsurance Opps Fund Ltd
05 December 2019
 

 

 

 

CATCo Reinsurance Opportunities Fund Ltd. (the "Company")

 

Directorate changes

 

 

To: Specialist Fund Segment, London Stock Exchange and Bermuda Stock Exchange

Date: 5 December 2019

 

 

The Board of Directors of the Company are pleased to announce the appointment of Arthur Jones as a non-executive Director of the Company with effect from the conclusion of a Board meeting of the Company held on 4 December 2019. Arthur will also chair the Company's Audit Committee.

 

Arthur is a Chartered Accountant with 35 years' experience in the financial services industry.

 

He is currently Chief Financial Officer of the Consolidated Group of Companies which provides corporate and accounting services to clients in, amongst others, the insurance and investment fund industries. He has been with the Consolidated Group of Companies since 1987. From 2005 to 2018, Arthur served on the Boards of Directors of a number of Bermuda-incorporated hedge and long-only equity funds managed by Martin Currie Group. He is a Bermuda resident.

 

At the date of this announcement, Arthur has no holding in the Ordinary shares or C shares of the Company.

 

There are no matters requiring disclosure pursuant to Listing Rule 9.6.13.

 

Arthur succeeds Alastair Barbour who, as announced on 26 February 2019, had indicated his intention to retire from the Board towards the end of 2019, and who now retires from the Board with immediate effect.

 

James Keyes, Chairman of the Company, commented:

 

"The Board is pleased to confirm Arthur's appointment while expressing our appreciation for Alastair's contribution to the Board and Audit Committee on which he has served over the last eight years. His insight, knowledge and experience have been invaluable. We wish Alastair well for the future."

 

 

For further information:

Markel CATCo Investment Management Ltd.

 

Judith Wynne

General Counsel

Telephone: +1 441 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way

Chief of Investor Marketing

Telephone: +1 441 493 9001

Email: mark.way@markelcatco.com

Numis Securities Limited

 

David Benda / Hugh Jonathan

Telephone: +44 (0) 20 7260 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGGGCPUPBGBC
Date   Source Headline
29th Aug 20183:51 pmRNSDirector/PDMR Shareholding
29th Aug 201812:08 pmRNSDirector/PDMR Shareholding
20th Aug 20187:00 amRNSNet Asset Value(s)
17th Aug 20187:00 amRNSHalf-year Report
16th Jul 20182:44 pmRNSNet Asset Value(s)
10th Jul 20182:57 pmRNSHolding(s) in Company
21st Jun 20185:09 pmRNSReplacement Share Interest Acquisition CEO Inv Mgr
21st Jun 20183:10 pmRNSShare Interests Acquisition by CEO of Inv Manager
21st Jun 201811:35 amRNSShare Interests Acquisition by CEO of Inv Manager
20th Jun 20181:42 pmRNSDirector/PDMR Shareholding
18th Jun 20187:00 amRNSNet Asset Value(s)
18th Jun 20187:00 amRNSShare Interests Acquisition by CEO of Inv Manager
1st Jun 20184:07 pmRNSPublication of Suppl.Prospcts
17th May 201810:00 amRNSShare Interests Acquisition by CEO of Inv Manager
16th May 20187:00 amRNSNet Asset Value(s)
15th May 201812:35 pmRNSDirector/PDMR Shareholding
14th May 201812:51 pmRNSDirector/PDMR Shareholding
14th May 201812:02 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSPortfolio Update
19th Apr 20181:58 pmRNSResult of AGM
19th Apr 20187:00 amRNSNet Asset Value(s)
29th Mar 20187:00 amRNSNet Asset Value(s)
21st Mar 20183:52 pmRNSHolding(s) in Company
20th Mar 201812:45 pmRNSPublication of Suppl.Prospcts
12th Mar 20187:00 amRNSFinal Results
5th Mar 20187:00 amRNSNet Asset Value(s)
15th Feb 20184:00 pmRNSPublication of Suppl.Prospcts
14th Feb 20183:26 pmRNSHolding(s) in Company
12th Feb 20181:34 pmRNSHolding(s) in Company
9th Feb 201810:46 amRNSHolding(s) in Company
2nd Feb 20187:00 amRNSPortfolio Update
1st Feb 201812:00 pmRNSPublication of Suppl.Prospcts
31st Jan 20184:20 pmRNSDividend Declaration
19th Jan 20187:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Jan 20187:00 amRNSPRIIPs Key Information Documents
12th Dec 20177:00 amRNSNet Asset Value(s)
8th Dec 20177:00 amRNSIssue of Equity - correction
7th Dec 20175:44 pmRNSHolding(s) in Company
7th Dec 20177:00 amRNSIssue of Equity
5th Dec 20179:52 amRNSHolding(s) in Company
29th Nov 20174:40 pmRNSIssue of Equity - Correction
28th Nov 20173:50 pmRNSIssue of Equity
15th Nov 201711:02 amRNSPublication of Suppl.Prospcts
13th Nov 20177:00 amRNSNet Asset Value(s)
8th Nov 20177:00 amRNSPublication of a Prospectus
7th Nov 20171:17 pmRNSResult of Special General Meeting
6th Nov 20174:45 pmRNSHolding(s) in Company
17th Oct 20171:04 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSNet Asset Value
13th Oct 201711:36 amRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.